Innovative beauty e-commerce, tightening and smoothing skin, relieving pain
Post-money valuation โ
$70.6M
As of Apr 2024 ยท from ASHLEY BLACK INC Preferred Stock 2 ยท pre-money + amount raised, not a traded price
Total raised
$3,388,843
Across 2 rounds since 2022
Latest share price
$7.00
ASHLEY BLACK INC Preferred Stock 2 offering price
Financials
FY2019โFY2024 ยท from SEC filings ยท hover any figure for its source
$13.1M
$3.1M
2019
$15.4M
$455K
2020
$15.4M
$522K
2021
$25.6M
$563K
2022
$18.3M
โ$3.3M
2023
$17.7M
โ$681K
2024
RevenueNet income โ beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$13,058,147
$15,369,802
$15,369,802
$25,611,647
$18,255,307
$17,747,944
Cost of goods sold
$4,776,667
$7,570,683
$7,570,683
$10,755,324
$7,907,577
$6,425,656
Gross margin
63%
51%
51%
58%
57%
64%
Net income
$3,117,101
$455,288
$522,237
$562,631
-$3,303,303
-$680,513
Taxes paid
$1
$1
$1
$25,081
$14,879
$11,400
Balance sheet
Cash
$2,863,173
$998,392
$998,392
$2,632,296
$356,939
$1,207,250
Accounts receivable
$273,914
$334,736
$334,736
$240,084
$306,278
$473,448
Total assets
$11,454,664
$12,066,695
$12,143,051
$18,228,921
$13,821,434
$14,905,069
Short-term debt
$3,667,578
$2,995,190
$3,249,881
$4,318,022
$3,465,537
$4,637,827
Long-term debt
$2,073,276
$3,151,408
$3,164,035
$4,548,989
$5,294,368
$5,063,603
Total liabilities
$5,740,854
$6,146,598
$6,413,916
$8,867,011
$8,759,905
$9,701,430
Other
Headcount
โ
12
โ
45
โ
32
Figures as reported by the issuer in the filing shown on hover. Each yearโs pill shows the assurance level of its filed statements โ audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didnโt state one. Headcount is the filingโs point-in-time count, not a year-end average. Manually corrected figures are marked โCorrectedโ.
A dashed amber step is a SAFE/note valuation cap โ a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
About this data. Figures are compiled from public sources โ SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages โ and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.